AbdelMageed, M.; Ali, H.; Olsson, L.; Lindmark, G.; Hammarström, M.-L.; Hammarström, S.; Sitohy, B.
The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome. Int. J. Mol. Sci. 2019, 20, 5793.
https://doi.org/10.3390/ijms20225793
AMA Style
AbdelMageed M, Ali H, Olsson L, Lindmark G, Hammarström M-L, Hammarström S, Sitohy B.
The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome. International Journal of Molecular Sciences. 2019; 20(22):5793.
https://doi.org/10.3390/ijms20225793
Chicago/Turabian Style
AbdelMageed, Manar, Haytham Ali, Lina Olsson, Gudrun Lindmark, Marie-Louise Hammarström, Sten Hammarström, and Basel Sitohy.
2019. "The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome" International Journal of Molecular Sciences 20, no. 22: 5793.
https://doi.org/10.3390/ijms20225793
APA Style
AbdelMageed, M., Ali, H., Olsson, L., Lindmark, G., Hammarström, M.-L., Hammarström, S., & Sitohy, B.
(2019). The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome. International Journal of Molecular Sciences, 20(22), 5793.
https://doi.org/10.3390/ijms20225793